電子臨床転帰アセスメントソリューション(eCOA)の世界市場2021-2026:成長・動向・新型コロナの影響・市場予測

◆英語タイトル:Electronic Clinical Outcome Assessment Solutions (eCOA) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
◆商品コード:MOR21MR124
◆発行会社(リサーチ会社):Mordor Intelligence
◆発行日:2021年2月
◆ページ数:115
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名利用)USD4,250 ⇒換算¥484,500見積依頼/購入/質問フォーム
Team User(5名利用)USD4,750 ⇒換算¥541,500見積依頼/購入/質問フォーム
Corporate License(法人利用)USD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMordor Intelligence社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Mordor Intelligence社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査資料では、世界の電子臨床転帰アセスメントソリューション(eCOA)市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、配信モード別(Webホスト、クラウドベース)分析、導入別(患者報告アウトカム(PRO)、臨床報告アウトカム(ClinRO)、介護者報告アウトカム(ObsRO)、パフォーマンスアウトカム(PerfO))分析、エンドユーザー別(製薬企業・バイオ製薬企業、委託研究機関、その他)分析、地域別分析、競争状況、市場機会/将来の見通しなどを掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・世界の電子臨床転帰アセスメントソリューション(eCOA)市場規模:配信モード別(Webホスト、クラウドベース)
・世界の電子臨床転帰アセスメントソリューション(eCOA)市場規模:導入別(患者報告アウトカム(PRO)、臨床報告アウトカム(ClinRO)、介護者報告アウトカム(ObsRO)、パフォーマンスアウトカム(PerfO))
・世界の電子臨床転帰アセスメントソリューション(eCOA)市場規模:エンドユーザー別(製薬企業・バイオ製薬企業、委託研究機関、その他)
・世界の電子臨床転帰アセスメントソリューション(eCOA)市場規模:地域別
・競争状況
・市場機会/将来の見通し
【レポートの概要】

The major factors found propelling the growth of the market include the high demand for clinical trials in emerging markets, high R&D spending of the pharmaceutical industry, increasing prevalence of diseases, and inclination from manual data interpretation to real-time data analysis are expected to offer significant growth opportunities for global players during the study period.

Moreover, regulatory agencies have increasingly highlighted the significance of evaluating broader characteristics of patient well-being to define therapeutic gain in an enhanced manner. As a result, clinical outcome assessments (COAs) are increasingly used to estimate the impact of treatments for various chronic disorders, and in some instances, these have played a major role in the regulatory approval of drugs.

However, data privacy concerns and high implementation costs are acting as major restraints for the growth of the market.

Key Market Trends

web-hosted eCOA Segment expected to Grow at Significant Rate

With the increasing use of eCOA, additional modifications have provided a detailed understanding of the proper use of eCOA, for more benefits and improvisation of the data quality.

The web-hosted eCOA gives more compatibility to clinicians, as it is easy to operate and can keep the whole record throughout the clinical trials, from Phase I to IV.

Web-hosted eCOA solutions help reduce the development timeline and provide faster results. These solutions are helpful in the administration of clinical trials. For instance, the web-hosted eCOA helps in real-time management, instant alerts, and consistency check during clinical trials.nWith increasing use of tablets and smartphones, web-hosted eCOA has become easily accessible. The ease of access is one of the prime factors responsible for the increasing use of web-hosted eCOA, among clinicians and patients.

North America Expected to have Significant Market Share

Electronic Clinical Outcome Assessment Solutions (eCOA) Market in North America is anticipated to grow significantly, due to rising clinical trials across the country. With the rising demand for drug development, the clinical trials are rapidly increasing in the United States and Canada.

In addition, constant advancements in eCOA modalities and strategic collaborations between major market players are contributing to the rising demand for these solutions in the country. For instance, In June 2018, OmniComm Systems Inc. and Kayentis entered a partnership, under the terms of the partnership, the two companies are expected to work together to provide life science clients with OmniComm’s TrialMaster electronic data capture (EDC) suite integrated with Clin’form, eCOA solution Suite from Kayentis, thereby, offering enhanced integration of the two platforms.

The clinicians across the region rely on novel technologies for data management. Owing to the significance of eCOA solutions in providing ease of access, clinicians are proffering these platforms for clinical trial management.

Competitive Landscape

Electronic Clinical Outcome Assessment Solutions (eCOA) market is moderately fragmented and competitive. Market players are focusing on new product launches and regional expansions to increase their market share. The key market players operating in the market include IQVIA Inc., Veeva Systems, Parexel International Corporation, Signant Health, WIRB-Copernicus Group amongst others.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

【レポートの目次】

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Externalization of Clinical Trial Studies by Large Pharmaceutical and Biopharmaceutical Companies
4.2.2 Growing Demand for Cloud Based Services
4.2.3 Constant Advancements in eCOA Modalities
4.3 Market Restraints
4.3.1 Data Security and Privacy Concerns
4.3.2 High Cost of Implementation
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Delivery Mode
5.1.1 Web Hosted
5.1.2 Cloud Based
5.2 By Approach
5.2.1 Patient-reported outcome (PRO)
5.2.2 Clinician-reported outcome (ClinRO)
5.2.3 Observer-reported outcome (ObsRO)
5.2.4 Performance outcome (PerfO)
5.3 End-User
5.3.1 Pharmaceutical and Biopharmaceutical Companies
5.3.2 Contract Research Organizations
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-Eastst and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Oracle Corporation
6.1.2 Castor EDC
6.1.3 Dassault Systmes (medidata)
6.1.4 ERT Clinical
6.1.5 IQVIA Inc.
6.1.6 Kayentis
6.1.7 Veeva Systems
6.1.8 Parexel International Corporation
6.1.9 Signant Health.
6.1.10 WIRB-Copernicus Group
6.1.11 Mednet Solutions

7 MARKET OPPORTUNITIES AND FUTURE TRENDS



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[電子臨床転帰アセスメントソリューション(eCOA)の世界市場2021-2026:成長・動向・新型コロナの影響・市場予測]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆